002042SZSE

2025 Independent Director Debriefing Report (Song Haitao)

Huafu Fashion Co., Ltd.·

✨ AI Summary

The 2025 Independent Directors Debriefing Report by Song Haitao outlines his compliance with relevant laws and regulations while serving as an independent director of Huafu Fashion Co., Ltd. He attended five board meetings and three shareholders' meetings, actively participating in discussions and voting. Key decisions included the approval of a related party transaction involving a real estate lease and the nomination of a non-independent director. The report emphasizes his commitment to safeguarding shareholder interests and maintaining corporate governance.

Summary generated by AI · Always verify with source document

Full Translation

Machine Translation· Azure Translator

Huafu Fashion Co., Ltd 2025 Independent Directors Debriefing Report Song Haitao

As an independent director of Huafu Fashion Co., Ltd. (hereinafter referred to as the "Company"), in 2025, I will comply with the "China Company Law of the People's Republic of China, Administrative Measures for Independent Directors of Listed Companies, Articles of Association and other relevant laws and laws The regulations and requirements of the regulations and systems give full play to the role of independent directors, fulfill their duties, be diligent and responsible, and safeguard the interests of the company and safeguard the interests of all shareholders, especially small and medium-sized shareholders. The performance of independent directors' duties in 2025 is now reported As follows.

  1. Annual performance of duties: I, Song Haitao, born in 1986, is a doctoral student, Chinese nationality, and has no permanent residency abroad. artificial intelligence , General robot, expert in the field of computing power infrastructure. He has worked in the State Power Investment Group, China Academy of Information and Communications Technology, He is currently the dean of Shanghai Jiao Tong University and Shanghai Institute of Artificial Intelligence, and the National Science Center for Translational Medicine in artificial intelligence technology Director of the heart. On May 24, 2025, I was deliberated and approved by the shareholders' meeting and became an independent director of the eighth board of directors of the company. The term of office is the same as that of the eighth board of directors. After self-examination, I have met the requirements of the "Management of Independent Directors of Listed Companies" during my tenure

The independence requirements stipulated in Article 6 of the Administrative Measures do not affect independence.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.